Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
North Carolina
MedTech
Lumexa Imaging IPO tallies $462.5M, doubling original target
Lumexa Imaging hauled in $462.5 million during its IPO, far exceeding the diagnostic services provider’s earlier target of $200 million.
Joseph Keenan
Dec 15, 2025 9:40am
Next-gen CRO unveils with access to 350-plus US sites
Dec 3, 2025 3:55pm
Thermo Fisher opens automated lab tools plant in N.C.
Aug 22, 2025 10:48am
Charles River to shutter North Carolina pathology site
Feb 4, 2025 6:00am
Bayer's Vividion pens $930M biobucks pact with Tavros
Oct 12, 2022 7:30am
The top biotech hubs in 2022
Jul 5, 2022 3:00am
